CMS proposes lower Medicare payments for 340B drugs at hospital outpatient departments
CMS proposed a 2027 Medicare rule that would reduce payments for certain 340B-acquired drugs at hospital outpatient departments, with the agency saying the change could lower costs for some beneficiaries if finalized.